Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway
Monotropein (Mon) is a kind of iridoid glycoside plant secondary metabolite primarily present in some edible and medicinal plants. The aim of this study was to investigate the effect of Mon on lipopolysaccharide (LPS)-induced inflammatory bone loss in mice and osteoclasts (OCs) derived from bone mar...
Main Authors: | Qi Zhang, Sijing Hu, Yuqiong He, Zile Song, Yi Shen, Zihui Zhao, Quanlong Zhang, Luping Qin, Qiaoyan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/19/3978 |
Similar Items
-
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01) -
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
by: Jianbo He, et al.
Published: (2023-12-01) -
BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1
by: Yufeng Zhang, et al.
Published: (2022-05-01) -
Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01) -
Monotropein: A comprehensive review of biosynthesis, physicochemical properties, pharmacokinetics, and pharmacology
by: Mingquan Wu, et al.
Published: (2023-03-01)